1.Ziyu Huang, et al, Tao Zuo*. Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum. Nature Metabolism, 2026. (最后通讯，影响因子: 27.5)
2.Weijie Wen...Tao Zuo*. Gut DNA virome enterotype dictates inflammation heterogeneity through tuning the phage-bacteria-sphingosine-intestine axis in Crohn’s disease. Cell Host & Microbe. 2026. (独立通讯，影响因子: 23.2，封面文章)
3.Yufeng Jin, Jincun Zhao*, Tao Zuo*. Potential impacts of antivirals on the virome. Cell Host & Microbe. 2026. (最后通讯，影响因子: 23.2，亮点文章)
4.Tao Zuo*. Pushing the frontier of gut microbiome health cross-kingdom and cross-organ. Nature Reviews Gastroenterology & Hepatology, 2026. (独立通讯，影响因子: 57.5)
5.F Zhang, Guicheng Zhou, et al, Tao Zuo*. Dietary urbanization destabilizes host-gut microbiome homeostasis and informs future microbiome-directed precision nutrition for human health. Cell Metabolism, 2025. (最后通讯，影响因子: 37)
6.Weijie Wen, Changqing Yang, Tao Zuo*. Viewing MASLD through an integrative gut microbiome lens. Nature Metabolism, 2025. (独立通讯，影响因子: 27.5)
7.Runping Su, Weijie, et al, Tao Zuo*. Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome. Gut, 2025. (最后通讯，影响因子: 24.6，封面文章)
8.Cao, Z., Fan, D., Sun, Y. et al, Tao Zuo*. The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice. Nature Communications 15, 1638 (2024). (最后通讯，影响因子:18.1)
9.Ziyu Huang, Yunyun Liu, Anna Phillips, Fen Zhang, Tao Zuo*. Varied prevalence and asymptomatic carriage of Cryptococcus gattii in the gut of Chinese populations. Lancet Microbe. 2025. (独立通讯，影响因子:21.9)
10.Nengneng Li, et al, Tao Zuo*. Fecal phageome transplantation alleviates intermittent intestinal inflammation in IBD and the timing of transplantation matters: a preclinical, proof-of-concept study in mice. Gut, 2024. (独立通讯，影响因子:24.6)
